BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8494713)

  • 1. Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.
    Blay JY; Lasset C; Carrie C; Chauvin F; Coiffier B; Gisselbrecht C; Clavel M; Rebattu P; Brunat-Mentigny M; Philip T
    Br J Cancer; 1993 May; 67(5):1136-41. PubMed ID: 8494713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients.
    Ghesquières H; Drouet Y; Sunyach MP; Sebban C; Chassagne-Clement C; Jouanneau E; Honnorat J; Biron P; Blay JY
    Hematol Oncol; 2013 Jun; 31(2):57-64. PubMed ID: 22886543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
    Blay JY; Conroy T; Chevreau C; Thyss A; Quesnel N; Eghbali H; Bouabdallah R; Coiffier B; Wagner JP; Le Mevel A; Dramais-Marcel D; Baumelou E; Chauvin F; Biron P
    J Clin Oncol; 1998 Mar; 16(3):864-71. PubMed ID: 9508167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors and primary cerebral lymphoma].
    Bataille B; Page P
    Neurochirurgie; 1997; 43(6):385-7. PubMed ID: 9706618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.
    Ferreri AJ; Blay JY; Reni M; Pasini F; Spina M; Ambrosetti A; Calderoni A; Rossi A; Vavassori V; Conconi A; Devizzi L; Berger F; Ponzoni M; Borisch B; Tinguely M; Cerati M; Milani M; Orvieto E; Sanchez J; Chevreau C; Dell'Oro S; Zucca E; Cavalli F
    J Clin Oncol; 2003 Jan; 21(2):266-72. PubMed ID: 12525518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
    Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial disease in non-Hodgkin's lymphoma.
    Venables GS; Proctor SJ; Bates D; Cartlidge NE; Shaw DA
    Q J Med; 1980; 49(194):111-31. PubMed ID: 7433631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
    Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
    J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients.
    Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Gómez J; Millá F; Feliu E
    Haematologica; 1998 Jun; 83(6):508-13. PubMed ID: 9676023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
    Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
    Gómez H; Hidalgo M; Casanova L; Colomer R; Pen DL; Otero J; Rodríguez W; Carracedo C; Cortés-Funes H; Vallejos C
    J Clin Oncol; 1998 Jun; 16(6):2065-9. PubMed ID: 9626205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cerebral lymphoma. A retrospective study of 27 cases.
    Grangier C; Coucke P; Croisille P; Guillemin C; Mirimanoff RO
    Strahlenther Onkol; 1994 Apr; 170(4):206-12. PubMed ID: 8165517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
    Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients.
    Tomlinson FH; Kurtin PJ; Suman VJ; Scheithauer BW; O'Fallon JR; Kelly PJ; Jack CR; O'Neill BP
    J Neurosurg; 1995 Apr; 82(4):558-66. PubMed ID: 7897514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
    Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
    Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.